2,3,4′,5‐TETRAHYDROXYSTILBENE‐2‐O‐β‐d‐GLUCOSIDE SUPPRESSES MATRIX METALLOPROTEINASE EXPRESSION AND INFLAMMATION IN ATHEROSCLEROTIC RATS

作者: Wei Zhang , Chun-Hua Wang , Feng Li , Wei-Zhong Zhu

DOI: 10.1111/J.1440-1681.2007.04824.X

关键词: EndocrinologyImmunologyInternal medicineMatrix metalloproteinaseInterleukinInflammationChemistryC-reactive proteinSimvastatinNecrosisTumor necrosis factor alphaInterleukin 6

摘要: … In the present study, TSG significantly and dose-dependently attenuated the hyperlipidaemic diet-induced alterations in serum lipid profile and increases in CRP, IL-6 and TNF-a levels. …

参考文章(38)
Markolf Hanefeld, Nikolaus Marx, Andreas Pfützner, Werner Baurecht, Georg Lübben, Efstrathios Karagiannis, Ulf Stier, Thomas Forst, Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein Journal of the American College of Cardiology. ,vol. 49, pp. 290- 297 ,(2007) , 10.1016/J.JACC.2006.08.054
Maria Pavlaki, Stanley Zucker, Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials. Cancer and Metastasis Reviews. ,vol. 22, pp. 177- 203 ,(2003) , 10.1023/A:1023047431869
Landin Boring, Jennifa Gosling, Michael Cleary, Israel F. Charo, Decreased lesion formation in CCR2 −/− mice reveals a role for chemokines in the initiation of atherosclerosis Nature. ,vol. 394, pp. 894- 897 ,(1998) , 10.1038/29788
Malay Mandal, Amritlal Mandal, Sudip Das, Tapati Chakraborti, Sajal Chakraborti, Clinical implications of matrix metalloproteinases. Molecular and Cellular Biochemistry. ,vol. 252, pp. 305- 329 ,(2003) , 10.1023/A:1025526424637
Wolfgang Koenig, Malte Sund, Margit Fröhlich, Hans-Günther Fischer, Hannelore Löwel, Angela Döring, Winston L. Hutchinson, Mark B. Pepys, C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men Results From the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation. ,vol. 99, pp. 237- 242 ,(1999) , 10.1161/01.CIR.99.2.237
P. Altieri, C. Brunelli, S. Garibaldi, A. Nicolino, S. Ubaldi, P. Spallarossa, L. Olivotti, P. Rossettin, A. Barsotti, G. Ghigliotti, Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. European Journal of Clinical Investigation. ,vol. 33, pp. 648- 656 ,(2003) , 10.1046/J.1365-2362.2003.01187.X
Zoltan Ungvari, Zsuzsanna Orosz, Aracelie Rivera, Nazar Labinskyy, Zhao Xiangmin, Susan Olson, Andrej Podlutsky, Anna Csiszar, Resveratrol increases vascular oxidative stress resistance American Journal of Physiology-heart and Circulatory Physiology. ,vol. 292, ,(2007) , 10.1152/AJPHEART.01258.2006
Sven Wassmann, Ulrich Laufs, Kirsten Müller, Christian Konkol, Katja Ahlbory, Anselm T. Bäumer, Wolfgang Linz, Michael Böhm, Georg Nickenig, Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 22, pp. 300- 305 ,(2002) , 10.1161/HQ0202.104081